Literature DB >> 10223585

Outpatient therapy for febrile neutropenia: who, when, and how?

O Uzun1, E J Anaissie.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10223585     DOI： 10.1093/jac/43.3.317

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  2 in total

1.  Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network.

Authors:  Edwin Pun Hui; Linda K S Leung; Terence C W Poon; Frankie Mo; Vicky T C Chan; Ada T W Ma; Annette Poon; Eugenie K Hui; So-Shan Mak; Maria Lai; Kenny I K Lei; Brigette B Y Ma; Tony S K Mok; Winnie Yeo; Benny C Y Zee; Anthony T C Chan
Journal:  Support Care Cancer       Date:  2010-09-04       Impact factor: 3.603

Review 2.  Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.

Authors:  Liat Vidal; Itsik Ben Dor; Mical Paul; Noa Eliakim-Raz; Ellisheva Pokroy; Karla Soares-Weiser; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2013-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.